Avant Technologies and Ainnova Complete Pivotal FDA Meeting for Vision AI Diabetic Retinopathy Platform

Avant Technologies and its JV partner, Ainnova, announced the completion of a pre-submission meeting with the U.S. FDA regarding Ainnova's Vision AI p...
Home/KnloSights/Clinical Trial Updates/Avant Technologies and Ainnova Complete Pivotal FDA Meeting for Vision AI Diabetic Retinopathy Platform